A review of the top 483 observations issued by the FDA indicates that many of them are related to the following categories: Lack of written, approved procedures where required Non-performance or insufficient performance of procedures Non-performance or insufficient performance of validation, calibration, or maintenance Insufficient follow up (e.g. CAPA) of failures To be sure, there